Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Lonza’s Synaffix and Sidewinder Therapeutics Sign Multi-Target Licence Agreement for Next-Generation Bispecific ADCs
Thursday, January 08, 2026Synaffix a Lonza company and Sidewinder Therapeutics have entered into a multitarget licensing agreement to support the development of nextgeneration bispecific antibodydrug conjugates ADCs for the treatment of solid tumours
Helix Signs Multi-Year Strategic Collaboration with GSK to Support Precision Medicine Development
Thursday, January 08, 2026Helix has entered into a multiyear strategic collaboration with GSK to support the development of precision medicine across a broad range of disease areas As part of the agreement GSK will gain access to Helixs expanding GenoSphere cohorts
BetterLife Pharma Participates in YAFO Capital Access Asia Partnering Forum During JPM Week to Foster North American-Asian Collaborations
Wednesday, January 07, 2026BetterLife Pharma Inc announced its participation in the YAFO Capital Access Asia Partnering Forum in San Francisco focusing on collaborations between North American life science companies and Asian investors and partners
Kelun-Biotech Secures Breakthrough Therapy Status in China for sac-TMT Plus Pembrolizumab in First-Line PD-L1-Positive NSCLC
Tuesday, January 06, 2026KelunBiotech has received Breakthrough Therapy Designation BTD in China for sacituzumab tirumotecan sacTMT used in combination with pembrolizumab as a firstline treatment for patients with locally advanced
Protara Therapeutics Gains FDA Breakthrough Therapy and Fast Track Status for TARA-002 in Children with Lymphatic Malformations
Tuesday, January 06, 2026Protara Therapeutics has received both Breakthrough Therapy and Fast Track designations from the US Food and Drug Administration FDA for TARA an investigational cellbased therapy for children
Kazakhstan Launches Full-Cycle Biopharmaceutical Complex in Alatau SEZ with $203M Investment
Friday, January 02, 2026Kazakhstan initiates a million biopharmaceutical complex in Alatau Special Economic Zone to produce drugs including APIs for oncology and rare diseases targeting exports to EAEU CIS and Middle East
HUTCHMED Announces Expanded Coverage on China's National Reimbursement Drug List and Inclusion in First Commercial Insurance Drug List
Thursday, January 01, 2026HUTCHMED achieves significant regulatory milestone with expanded inclusion on Chinas National Reimbursement Drug List and the inaugural Commercial Health Insurance Innovative Drug List enhancing drug accessibility
Insilico Medicine Successfully Lists on Hong Kong Stock Exchange in Landmark Biotech IPO
Wednesday, December 31, 2025Insilico Medicine an AIdriven drug discovery leader backed by Qiming Venture Partners debuted on the Hong Kong Stock Exchange today with a market cap exceeding HK billion
South Korea’s pharma industry faces regulatory showdown over sweeping drug price cuts and reimbursement reforms
Monday, December 29, 2025South Koreas pharmaceutical industry is preparing for an intense confrontation with policymakers over expansive drug price cuts and reimbursement reforms that could reshape margins market access and longterm RD commitments
ABL Bio Secures $55 Million from Eli Lilly for Grabody Platform License and Equity Investment
Friday, December 26, 2025South Korean biotech ABL Bio receives million upfront and million equity from Eli Lilly to advance its Grabody bispecific antibody platform across multiple therapeutic modalities
